C07F 9/5728
Condensed with carbocyclic rings or carbocyclic ring systems
Official title: {condensed with carbocyclic rings or carbocyclic ring systems}
C07F9/5728 (Condensed with carbocyclic rings or carbocyclic ring systems) appears on 476 US grants and 514 published applications in this corpus.
Search patents in C07F- Granted patents
- 476
- Published applications
- 514
- Assignees
- 281
- Inventors
- 1,401
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 3 | 0 |
| 1984 | 6 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 8 | 0 |
| 1995 | 8 | 0 |
| 1996 | 10 | 0 |
| 1997 | 11 | 0 |
| 1998 | 7 | 0 |
| 1999 | 10 | 0 |
| 2000 | 7 | 0 |
| 2001 | 10 | 0 |
| 2002 | 11 | 13 |
| 2003 | 9 | 13 |
| 2004 | 12 | 26 |
| 2005 | 9 | 20 |
| 2006 | 21 | 20 |
| 2007 | 12 | 19 |
| 2008 | 14 | 20 |
| 2009 | 12 | 18 |
| 2010 | 24 | 15 |
| 2011 | 12 | 15 |
| 2012 | 11 | 17 |
| 2013 | 13 | 12 |
| 2014 | 13 | 12 |
| 2015 | 14 | 23 |
| 2016 | 10 | 21 |
| 2017 | 17 | 18 |
| 2018 | 14 | 24 |
| 2019 | 25 | 20 |
| 2020 | 11 | 19 |
| 2021 | 14 | 14 |
| 2022 | 15 | 30 |
| 2023 | 18 | 34 |
| 2024 | 19 | 31 |
| 2025 | 15 | 38 |
| 2026 | 14 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- Conjugates including a detectable moiety7 Jul 2026US 12,673,938 B2Ventana Medical Systems, Inc.
- Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use30 Jun 2026US 12,668,605 B2Compass Pathfinder Limited
- Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use23 Jun 2026US 12,662,498 B2Compass Pathfinder Limited
- Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use2 Jun 2026US 12,643,917 B2Compass Pathfinder Limited
- Non-Peptide Small Molecule FGF14:Nav1.6 Channel Complex Protein-Protein Interaction Modulators1 Oct 2026US 2026/0297027 A1Board of Regents, The University of Texas System
- Conjugates including a detectable moiety1 Oct 2026US 2026/0297063 A1Ventana Medical Systems, Inc.
- Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use10 Sep 2026US 2026/0265276 A1Compass Pathfinder Limited
- Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use10 Sep 2026US 2026/0265277 A1Compass Pathfinder Limited
- Processes of preparing psilocin and psilocybin10 Sep 2026US 2026/0265278 A1
Most cited
By later US patents
- Indole analogs of mevalonolactone and derivatives thereof174US 5,354,772 ASandoz Pharm. Corp. · 1994
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001
- Modified PSMA ligands and uses related thereto119US 6,875,886 B2Beth Israel Deaconess Medical Center, Inc. · 2005
- Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase117US 6,489,476 B1Metabasis Therapeutics, Inc. · 2002
- Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof107US 4,739,073 ASandoz Pharmaceuticals Corp. · 1988